Related news for:
A drug currently in clinical trials has the potential to improve the survival rate of Australians diagnosed with acute myeloid leukaemia.
Researchers from Mater Research are pioneering a new approach to symptom relief by trialling medicinal cannabis in advanced cancer patients, as part of an Australian-first trial.
Mater Misericordiae Ltd (MML) is seeking volunteers to join the Human Research Ethics Committee (HREC).
Queensland Scientists have discovered a possible link between Parkinson’s disease and a gene impacted by a neurotoxin found in blue-green algae.
Associate Professor Kym Rae has recently joined Mater as the Principal Research Fellow for Indigenous Health at Mater Research.
On 11 February we celebrate International Day of Women and Girls in Science to acknowledge the outstanding contribution that women make to STEM related fields.
February is Ovarian Cancer Awareness Month held to educate people however Mater is providing hope with research and treatment.
Mater Researcher A/Prof Kristen Radford has been awarded a 2020 Fulbright Future Scholarship allowing her to progress her cancer research with a four month sabbatical at the Tisch Cancer Institute.
The team at Mater Research have started 2020 with a number of success stories from awards to promotions and new appointments our research team have been busy—and it’s only the third week of January.
Mater Research and Mater Mother’s Hospital are holding the second round of the Queensland Family Cohort Study and are looking for expectant parents to participate.
Congratulations to Dr Catherine Franklin and Dr Sinead Barry who have been announced as the next Betty McGrath Fellowship recipients.